Estrogen replacement therapy decreases platelet-activating factor-acetylhydrolase activity in post-menopausal women

Maturitas

Volumn 31, Issue 3, 1999, Pages 249-253

  Yoshimura, Toshihiro ^a   Ohshige, Akihiro ^a   Maeda, Takahiro ^a   Ito, Masaharu ^b   Okamura, Hitoshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Estrogen replacement therapy; Lipoprotein; Platelet activating factor acetylhydrolase; Post menopausal women

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CHOLESTEROL; ESTROGEN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN TISSUE; LIPID BLOOD LEVEL; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; THROMBOCYTE COUNT;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MIDDLE AGED; PHOSPHOLIPASES A; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION; PLATELET COUNT; POSTMENOPAUSE; TIME FACTORS;

EID: 0033039246     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(99)00004-3     Document Type: Article

References (17)

1. Speroff L, Glass R, Kase N. Menopause and postmenopausal hormone therapy. In: Clinical Gynecologic Endocrinology and Infertility. 5th ed. Baltimore: Williams & Wilkins, 1994;583-650.
2. Speroff L, Glass R, Kase N. Oral contraception. In: Clinical Gynecologic Endocrinology and Infertility. 5th ed. Baltimore: Williams & Wilkins, 1994;715-764.
3. Kloprogge E., Akkerman J.W.N. Binding kinetics of PAF-acether (l-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets. J. Biochem. 223:1984;901-909.
4. Ostermann G., Till U., Theilmann K. Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-Acether) and exogenous arachidonic acid in stimulation of human blood platelets. Thrombo. Res. 30:1984;409-418.
5. Frenkel R.A., Muguruma K., Johnston J.M. The biochemical role of platelet-activating factor in reproduction. Prog. Lipid. Res. 35:1996;155-168.
6. Maki N., Hoffman D.R., Johnston J.M. Platelet-activating factor acetylhydrolase activity in maternal, fetal, and newborn rabbit plasma during pregnancy and lactation. Proc. Natl. Acad. Sci. USA. 85:1988;728-732.
7. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
8. Rowan R.M., Fraser C., Gray J.H., McDonald G.A. The Coulter Counter Model S Plus - the shape of things to come. Clin. Lab. Haematol. 1:1979;29-40.
9. Crook D., Cust M.P., Gangar K.F., Worthington M., Hillard T.C., Stevenson J.C. et al. Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins. Am. J. Obstet. Gynecol. 166:1992;950-955.
10. Chazov E.I., Tertov V.V., Orekhov A.N., Lyakishev A.A., Perova N.V., Kurdanov K.A. et al. Atherogenicity of blood serum from patients with coronary heart disease. Lancet. 2(8507):1986;595-598.
11. Ohshige A., Ito M., Koyama H., Maeda T., Yoshimura T., Okamura H. Effects of estrogen and progesterone on platelet-activating factor-acetylhydrolase activity in ovariectomized rats. Artery. 21:1994;234-242.
12. Ohshige A., Ito M., Koyama H., Maeda T., Yoshimura T., Okamura H. Effects of estrogen and progesterone on plasma platelet-activating factor-acetylhydrolase activity and low-density lipoprotein cholesterol concentration in men. Artery. 22:1996;115-124.
13. Yasuda K., Johnston J.M. The hormonal regulation of platelet-activating factor-acetylhydrolase in the rat. Endocrinology. 130:1992;708-716.
14. Stafforini D.M., McIntyre T.M., Carter M.E., Prescott S.M. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. J. Biol. Chem. 262:1987;4215-4222.
15. Satoh K., Imaizumi T., Yoshida H., Kawamura Y., Takamatsu S., Takamatsu M., Mizuno S. Platelet-activating factor acetylhydrolase in plasma lipoproteins of healthy men and women. Clinica. Chemica. Acta. 202:1991;95-103.
16. Stephens C.J., Graham R.M., Yadava O.P., Leong L.L., Sturm M.J., Taylor R.R. Plasma platelet activating factor degradation and serum lipids after coronary bypass surgery. Cardiovasc. Res. 26:1992;25-31.
17. Karpatkin S. Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets. J. Clin. Invest. 48:1969;1073-1082.